AGO1
AGO1 (argonaute RISC component 1, also known as hAGO1 and EIF2C1) is a member of the argonaute family that binds small RNAs and is required for RNA-mediated gene silencing. It represses the translation of mRNAs complementary to the microRNAs or short interfering RNAs it carries. Browse Assay Genie's current range of AGO1 research reagents below, or read on for the biology behind the target.
AGO1 is required for RNA interference (RNAi). It binds short RNAs such as microRNAs (miRNAs) and short interfering RNAs (siRNAs) and represses the translation of mRNAs that are complementary to them. Unlike some other argonaute proteins, AGO1 lacks endonuclease activity and does not appear to cleave its target mRNAs. NCBI Gene also describes a role for the protein in the degradation of miRNA-bound mRNA targets.
The AGO1 protein is also needed for transcriptional gene silencing (TGS) of promoter regions that are complementary to bound short antigene RNAs (agRNAs). It belongs to the argonaute family, Ago subfamily, and is localised to the cytoplasm and to P-bodies. HGNC places the AGO1 gene in the groups of RISC loading complex subunits and the argonaute RISC component family. Its mouse ortholog is Ago1.
The gene has previously been named eukaryotic translation initiation factor 2C, 1 (EIF2C1) and argonaute RISC catalytic component 1. Alternatively spliced transcript variants encoding different isoforms have been reported. A more recent study identified the AGO1 gene as an authentic stop codon readthrough target, so that its mRNA can give rise to an additional C-terminally extended isoform through use of an alternative in-frame termination codon.
AGO1 is required for RNAi and binds miRNAs and siRNAs, making it a central protein for studying small RNA-directed silencing.
AGO1 represses translation of mRNAs complementary to its bound small RNAs, without cleaving them, which informs work on miRNA-mediated control.
AGO1 contributes to silencing of promoter regions complementary to bound antigene RNAs, a route for studying RNA-directed transcriptional control.
The AGO1 gene is a reported readthrough target that can yield a C-terminally extended isoform, relevant to translation termination studies.
AGO1 binds small RNAs such as miRNAs and siRNAs and represses translation of complementary mRNAs. It lacks endonuclease activity and does not appear to cleave targets. It is also required for transcriptional gene silencing of promoters complementary to bound antigene RNAs.
AGO1 is also called hAGO1 and EIF2C1, and earlier names include eukaryotic translation initiation factor 2C, 1 and argonaute RISC catalytic component 1. Alternatively spliced variants exist, and stop codon readthrough can produce a C-terminally extended isoform.
The mouse ortholog is Ago1. Human AGO1 belongs to the argonaute family, Ago subfamily, alongside AGO2, AGO3 and AGO4. Check the datasheet of any product for its validated reactivity.
Other argonaute family members involved in RNA interference and small RNA-mediated gene silencing.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UL18; product specifications from Assay Genie datasheets.